Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001–2005 using the Japan Adult Leukemia Study Group AML201 protocols-Reference-Cited by-同舟云学术

Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001–2005 using the Japan Adult Leukemia Study Group AML201 protocols

Published:2018-06-02 Issue:12 Volume:26 Page:4187-4198
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Kato Hideaki, ,Fujita Hiroyuki^ORCID,Akiyama Nobu,Kimura Shun-ichi,Hiramoto Nobuhiro,Hosono Naoko,Takahashi Tsutomu,Shigeno Kazuyuki,Minamiguchi Hitoshi,Miyatake Junichi,Handa Hiroshi,Kanda Yoshinobu,Yoshida Minoru,Miyawaki Shuichi,Ohtake Shigeki,Naoe Tomoki,Kiyoi Hitoshi,Matsumura Itaru,Miyazaki Yasushi

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4292-0/fulltext.html

Reference23 articles.

1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93. https://doi.org/10.1093/cid/cir073

2. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J, ESMO Guidelines Committee (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v118. https://doi.org/10.1093/annonc/mdw325

3. Engels EA, Lau J, Barza M (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 16:1179–1187. https://doi.org/10.1200/JCO.1998.16.3.1179

4. Kobayashi T, Miyawaki S, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Ohmoto E, Oh H, Jinnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Matsuoka A, Tomonaga M, Ohno R (2012) Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. J Clin Oncol 14:204–213. https://doi.org/10.1200/JCO.1996.14.1.204

5. Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, Yoshida M, Murakami H, Naoe T, Shimoyama M, Tsukada T, Takeo T, Teshima H, Onozawa Y, Fujimoto K, Kuriyama K, Horiuchi A, Kimura I, Minami S, Miura Y, Kageyama S, Tahara T, Masaoka T, Shirakawa S, Saito H (1993) Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG). Cancer 71:3888–3895

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel biomarkers to identify complicated course of febrile neutropenia in hematological patients receiving intensive chemotherapy;European Journal of Haematology;2024-07-03

2. Fluoroquinolone Prophylaxis during Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia – Pros and Cons;Acta Haematologica;2023-11-21

3. Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine;Hematology, Transfusion and Cell Therapy;2023-08

4. Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies;Frontiers in Cellular and Infection Microbiology;2023-06-30

5. Surgical Indications in All Diagnostic and Care Pathways (DTCP) Settings;Pearls and Pitfalls in Skin Ulcer Management;2023